{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T11:54:05Z","timestamp":1770724445618,"version":"3.49.0"},"reference-count":54,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/j.clbc.2016.02.006","type":"journal-article","created":{"date-parts":[[2016,2,13]],"date-time":"2016-02-13T15:28:23Z","timestamp":1455377303000},"page":"145-154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Clinical Outcomes and Toxicity of Proton Radiotherapy for Breast Cancer"],"prefix":"10.1016","volume":"16","author":[{"given":"Vivek","family":"Verma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chirag","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minesh P.","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2016.02.006_bib1","unstructured":"Particle Therapy Co-Operative Group. Particle Therapy Centers. Available at: http:\/\/www.ptcog.ch\/. Accessed: July 8,\u00a02015."},{"key":"10.1016\/j.clbc.2016.02.006_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.clon.2016.01.034","article-title":"Clinical Outcomes of Proton Radiotherapy for Uveal Melanoma","author":"Verma","year":"2016","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.clbc.2016.02.006_bib3","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.semradonc.2013.01.004","article-title":"Comparing dosimetric, morbidity, quality of life, and cancer control outcomes after 3D conformal, intensity-modulated, and proton radiation therapy for prostate cancer","volume":"23","author":"Pearlstein","year":"2013","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.clbc.2016.02.006_bib4","first-page":"252","article-title":"Cancer treatment and survivorship statistics, 2014","volume":"64","author":"DeSantis","year":"2014","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clbc.2016.02.006_bib5","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1080\/02841860500355918","article-title":"The potential of proton beam radiation therapy in breast cancer","volume":"44","author":"Bjork-Eriksson","year":"2005","journal-title":"Acta Oncol"},{"key":"10.1016\/j.clbc.2016.02.006_bib6","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/PPO.0b013e318053cdb0","article-title":"Is it time to use protons for breast cancer?","volume":"13","author":"MacDonald","year":"2007","journal-title":"Cancer J"},{"key":"10.1016\/j.clbc.2016.02.006_bib7","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1053\/j.seminoncol.2014.10.001","article-title":"Special cases for proton beam radiotherapy: re-irradiation, lymphoma, and breast cancer","volume":"41","author":"Plastaras","year":"2014","journal-title":"Semin Oncol"},{"key":"10.1016\/j.clbc.2016.02.006_bib8","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S0360-3016(01)01760-6","article-title":"Pulmonary toxicity after radiotherapy in primary breast cancer patients: results from a randomized chemotherapy study","volume":"52","author":"Hernberg","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clbc.2016.02.006_bib9","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/S0360-3016(02)04156-1","article-title":"Myocardial perfusion changes in patients irradiated for left-sided breast cancer and correlation with coronary artery distribution","volume":"55","author":"Lind","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clbc.2016.02.006_bib10","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer","volume":"368","author":"Darby","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clbc.2016.02.006_bib11","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.ijrobp.2007.10.034","article-title":"Risk of a second malignant neoplasm after cancer in childhood treated with radiotherapy: correlation with the integral dose restricted to the irradiated fields","volume":"70","author":"Nguyen","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clbc.2016.02.006_bib12","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1016\/j.ijrobp.2006.03.017","article-title":"Accelerated partial breast irradiation using proton beams: initial dosimetric experience","volume":"65","author":"Taghian","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clbc.2016.02.006_bib13","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1016\/j.ijrobp.2006.04.025","article-title":"Dosimetric comparison of proton and photon three-dimensional, conformal, external beam accelerated partial breast irradiation techniques","volume":"65","author":"Kozak","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clbc.2016.02.006_bib14","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.radonc.2008.09.027","article-title":"Dosimetric comparison of four different external beam partial breast irradiation techniques: three dimensional conformal radiotherapy, intensity-modulated radiotherapy, helical tomotherapy, and proton beam therapy","volume":"90","author":"Moon","year":"2009","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clbc.2016.02.006_bib15","doi-asserted-by":"crossref","first-page":"S245","DOI":"10.1016\/j.ijrobp.2013.06.637","article-title":"Cardiac-sparing postmastectomy proton radiation therapy for women with stage III, loco-regional breast cancer: a dosimetric comparison study","volume":"87","author":"Fagundes","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clbc.2016.02.006_bib16","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10549-014-3149-6","article-title":"Whole breast proton irradiation for maximal reduction of heart dose in breast cancer patients","volume":"148","author":"Mast","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/j.clbc.2016.02.006_bib17","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.3109\/0284186X.2015.1011756","article-title":"Proton beam versus photon beam dose to the heart and left anterior descending artery for left-sided breast cancer","volume":"54","author":"Lin","year":"2015","journal-title":"Acta Oncol"},{"key":"10.1016\/j.clbc.2016.02.006_bib18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.radonc.2013.03.028","article-title":"Intensity modulated proton therapy for postmastectomy radiation of bilateral implant reconstructed breasts: a treatment planning study","volume":"107","author":"Jimenez","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clbc.2016.02.006_bib19","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1097\/COC.0000000000000250","article-title":"Regional Nodal Irradiation: Examining the Clinical Implications of Randomized Trials","volume":"39","author":"Shah","year":"2016","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.clbc.2016.02.006_bib20","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJMoa1415340","article-title":"Regional nodal irradiation in early- stage breast cancer","volume":"373","author":"Whelan","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clbc.2016.02.006_bib21","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1415369","article-title":"Internal mammary and medial supraclavicular irradiation in breast cancer","volume":"373","author":"Poortmans","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clbc.2016.02.006_bib22","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0360-3016(02)04210-4","article-title":"Potential role of intensity-modulated photons and protons in the treatment of the breast and regional nodes","volume":"55","author":"Lomax","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clbc.2016.02.006_bib23","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0167-8140(02)00266-9","article-title":"Node-positive left-sided breast cancer patients after breast-conserving surgery: potential outcomes of radiotherapy modalities and techniques","volume":"65","author":"Johansson","year":"2002","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clbc.2016.02.006_bib24","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ijrobp.2009.02.062","article-title":"Postoperative proton radiotherapy for localized and locoregional breast cancer: potential for clinically relevant improvements?","volume":"76","author":"Ares","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clbc.2016.02.006_bib25","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1748-717X-8-71","article-title":"Proton radiotherapy for chest wall and regional lymphatic radiation; dose comparisons and treatment delivery","volume":"8","author":"MacDonald","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.clbc.2016.02.006_bib26","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/COC.0b013e318280d614","article-title":"Can proton therapy improve the therapeutic ratio in breast cancer patients at risk for nodal disease?","volume":"37","author":"Xu","year":"2014","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.clbc.2016.02.006_bib27","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ijrobp.2013.01.038","article-title":"Proton therapy for breast cancer after mastectomy: early outcomes of a prospective clinical trial","volume":"86","author":"MacDonald","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clbc.2016.02.006_bib28","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ijrobp.2015.01.005","article-title":"Early toxicity in patients treated with postoperative proton therapy for locally advanced breast cancer","volume":"92","author":"Cuaron","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clbc.2016.02.006_bib29","doi-asserted-by":"crossref","unstructured":"Bradley J, Dagan R, Ho MW, et\u00a0al. Initial report of a prospective dosimetric and clinical feasibility trial demonstrates the potential of protons to increase the therapeutic ratio in breast cancer compared with photons [e-pub ahead of print]. Int J Radiat Oncol Biol Phys. http:\/\/dx.doi.org\/10.1016\/j.ijrobp.2015.09.018.","DOI":"10.1016\/j.ijrobp.2015.09.018"},{"key":"10.1016\/j.clbc.2016.02.006_bib30","unstructured":"Iftekaruddin Z, McGee L, Maliekel J, Dunn M, Hartsell W. Acute toxicity outcomes in breast cancer patients treated with adjuvant proton therapy. Presented at the Particle Therapy Co-Operative Group North America 2nd Annual Meeting, 22 May 2015, San Diego, California. Available at: http:\/\/www.grupio.com\/events_2\/index.php?event_id=11080. Accessed: July 1, 2015"},{"key":"10.1016\/j.clbc.2016.02.006_bib31","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ijsu.2010.02.007","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"8","author":"Moher","year":"2010","journal-title":"Int J Surg"},{"key":"10.1016\/j.clbc.2016.02.006_bib32","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ijrobp.2014.04.008","article-title":"Long-term cosmetic outcomes and toxicities of proton beam therapy compared with photon-based 3-dimensional conformal accelerated partial-breast irradiation: a phase 1 trial","volume":"90","author":"Galland-Girodet","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clbc.2016.02.006_bib33","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ijrobp.2014.05.1308","article-title":"Partial breast radiation therapy with proton beam: 5-year results with cosmetic outcomes","volume":"90","author":"Bush","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clbc.2016.02.006_bib34","unstructured":"Ovalle V, Strom EA, Shaitelman SF, et\u00a0al. Proton partial breast irradiation: detailed description of acute clinico-radiologic effects. Presented at the Particle Therapy Co-Operative Group North America 2nd Annual Meeting, 22 May 2015, San Diego, California. Available at: http:\/\/www.grupio.com\/events_2\/index.php?event_id=11080. Accessed: July 1, 2015"},{"key":"10.1016\/j.clbc.2016.02.006_bib35","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.radonc.2013.06.008","article-title":"Phase II trial of proton beam accelerated partial breast irradiation in breast cancer","volume":"108","author":"Chang","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clbc.2016.02.006_bib36","unstructured":"Sckolnik S, Simpson D, Mascia A, Lepage R, Giap H. Intensity modulated proton therapy for accelerated partial breast irradiation. Presented at the Particle Therapy Co-Operative Group North America 2nd Annual Meeting, 22 May 2015, San Diego, California. Available at: http:\/\/www.grupio.com\/events_2\/index.php?event_id=11080. Accessed: July 1, 2015"},{"key":"10.1016\/j.clbc.2016.02.006_bib37","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.ijrobp.2007.10.025","article-title":"Risk of subclinical micrometastatic disease in the supraclavicular nodal bed according to the anatomic distribution in patients with advanced breast cancer","volume":"71","author":"Reed","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clbc.2016.02.006_bib38","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1748-717X-8-81","article-title":"Post mastectomy LINAC IMRT irradiation of chest wall and regional lymphatics: dosimetry data and acute toxicities","volume":"8","author":"Ma","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.clbc.2016.02.006_bib39","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.ijrobp.2015.02.022","article-title":"Delineation of supraclavicular target volumes in breast cancer radiation therapy","volume":"92","author":"Brown","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clbc.2016.02.006_bib40","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.3109\/0284186X.2014.925579","article-title":"CT-planned internal mammary node radiotherapy in the DBCG-IMN study: benefit versus potentially harmful effects","volume":"53","author":"Thorsen","year":"2014","journal-title":"Acta Oncol"},{"key":"10.1016\/j.clbc.2016.02.006_bib41","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/j.ijrobp.2015.07.2292","article-title":"Exposure of the heart in breast cancer radiation therapy: a systematic review of heart doses published during 2003 to 2013","volume":"93","author":"Taylor","year":"2015","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clbc.2016.02.006_bib42","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1001\/jamaoncol.2015.2666","article-title":"Acute and short-term toxic effects of conventionally fractionated vs hypofractionated whole-breast irradiation: a randomized clinical trial","volume":"1","author":"Shaitelman","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clbc.2016.02.006_bib43","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/j.ijrobp.2004.04.044","article-title":"Postmastectomy CT-based electron beam radiotherapy: dosimetry, efficacy, and toxicity in 118 patients","volume":"60","author":"Spierer","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clbc.2016.02.006_bib44","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.radonc.2013.05.008","article-title":"Breast-conserving therapy with partial or whole breast irradiation: ten-year results of the Budapest randomized trial","volume":"108","author":"Polgar","year":"2013","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clbc.2016.02.006_bib45","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.radonc.2010.01.019","article-title":"Accelerated partial breast irradiation using high-dose-rate interstitial brachytherapy: 12-year update of a prospective clinical study","volume":"94","author":"Polgar","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clbc.2016.02.006_bib46","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.ijrobp.2007.12.056","article-title":"A\u00a0phase II trial of brachytherapy alone after lumpectomy for select breast cancer: tumor control and survival outcomes of RTOG 95-17","volume":"72","author":"Arthur","year":"2008","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clbc.2016.02.006_bib47","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.brachy.2013.08.002","article-title":"RTOG 95-17, a phase II trial to evaluate brachytherapy as the sole method of radiation therapy for stage I and II breast carcinoma\u2014year 5 toxicity and cosmesis","volume":"13","author":"Rabinovitch","year":"2014","journal-title":"Brachytherapy"},{"key":"10.1016\/j.clbc.2016.02.006_bib48","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.radonc.2011.03.011","article-title":"Twelve-year clinical outcomes and patterns of failure with accelerated partial breast irradiation versus whole-breast irradiation: results of a matched-pair analysis","volume":"100","author":"Shah","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clbc.2016.02.006_bib49","doi-asserted-by":"crossref","first-page":"3279","DOI":"10.1245\/s10434-013-3158-4","article-title":"Treatment efficacy with accelerated partial breast irradiation (APBI): final analysis of the American Society of Breast Surgeons MammoSite breast brachytherapy trial","volume":"20","author":"Shah","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"suppl","key":"10.1016\/j.clbc.2016.02.006_bib50","article-title":"Early toxicity results with 3D conformal external beam (CEBT) from the NSABP B-39\/RTOG 0413 accelerated partial breast irradiation (APBI) trial","volume":"29","author":"Julian","year":"2011","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2016.02.006_bib51","doi-asserted-by":"crossref","first-page":"4038","DOI":"10.1200\/JCO.2013.50.5511","article-title":"Interim cosmetic and toxicity results from RAPID: a randomized trial of accelerated partial breast irradiation using 3D conformal external beam radiation therapy","volume":"31","author":"Olivotto","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clbc.2016.02.006_bib52","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ijrobp.2013.05.039","article-title":"Extended (5-year) outcomes of accelerated partial breast irradiation using MammoSite balloon brachytherapy: patterns of failure, patient selection, and dosimetric correlates for late toxicity","volume":"88","author":"Vargo","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clbc.2016.02.006_bib53","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.29882","article-title":"A systematic review of the cost and cost-effectiveness studies of proton radiotherapy","author":"Verma","year":"2016","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2016.02.006_bib54","unstructured":"ClinicalTrials.gov identifier NCT02603341. Pragmatic randomized trial of proton vs. photon therapy for patients with non-metastatic breast cancer: a radiotherapy comparative effectiveness (RADCOMP) consortium trial. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02603341. Accessed: December 13,\u00a02015."}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152682091630026X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152682091630026X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:14:25Z","timestamp":1761513265000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152682091630026X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6]]},"references-count":54,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S152682091630026X"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2016.02.006","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Outcomes and Toxicity of Proton Radiotherapy for Breast Cancer","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2016.02.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}